(Q39599692)

13 September 2017

title

Effects of β-mercaptoethanol and chelating agents on the stability and activation of creatine kinase in serum (English)

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

18 April 2022

Effects of beta-mercaptoethanol and chelating agents on the stability and activation of creatine kinase in serum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95909

18 April 2022

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

18 April 2022

author name string

McDonald JM

4

1 reference

13 September 2017

J. L. Rollo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95909

18 April 2022

J. E. Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95909

18 April 2022

J. H. Ladenson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95909

18 April 2022

J. M. McDonald

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95909

18 April 2022

D. E. Bruns

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95909

18 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=95909

18 April 2022

publication date

1 July 1978

1 reference

13 September 2017

15 July 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=95909

full work available at URL

18 April 2022

https://api.elsevier.com/content/article/PII:0009898178903388?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

https://api.elsevier.com/content/article/PII:0009898178903388?httpAccept=text/plain

18 April 2022

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

18 April 2022

1 reference

13 September 2017

volume

87

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

189-198

1 reference

SERUM CREATINE PHOSPHOKINASE (CPK) ACTIVITY IN DISORDERS OF HEART AND SKELETAL MUSCLE

13 September 2017

cites work

2

61

1015

Hess

1964

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

18 April 2022

5

36

711

Committee on Enzymes of the Scandinavian Society for Clinical Chemistry Clinical Physiology

publication date

1976

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

The New England Journal of Medicine

18 April 2022

9

297

894

Nierenberg

1977

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

Creatine kinase activity in serum and uric acid solution

18 April 2022

12

70

285

Warren

1976

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

Effect of incubation in human plasma on electrophoretic mobility of brain-type creatine phosphokinase

18 April 2022

13

73

257

Cho

1976

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

Quantification of serum creatine phosphokinase isoenzyme activity

18 April 2022

15

33

650

Roberts

1974

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

Determination of creatine kinase isoenzyme MB (CK-MB): comparison of methods and clinical evaluation

18 April 2022

16

80

23

Fiolet

1977

1 reference

https://api.crossref.org/works/10.1016/0009-8981(78)90338-8

18 April 2022

Identifiers

1 reference

release_ct3iqfsbszeq3fenv6h7gedzre

13 September 2017

Fatcat ID

0 references

1 reference